New drug combination extends survival with advanced kidney cancer. It’s poised to enter a competitive treatment market

first_imgBiotech [email protected] Log In | Learn More New drug combination extends survival with advanced kidney cancer. It’s poised to enter a competitive treatment market STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+. First 30 days free. GET STARTED Adam Feuerstein Patients with advanced kidney cancer live longer when treated with a combination of drugs from Bristol Myers Squibb and Exelixis compared to an older medicine, according to new clinical trial results reported Sunday.Convincing physicians to prescribe the new combination regimen for kidney cancer patients, though, will face a challenge: equally effective treatments already in use. GET STARTED What is it?center_img About the Author Reprints Adobe Senior Writer, Biotech Adam is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He’s also a co-host of “The Readout LOUD” podcast. What’s included? By Adam Feuerstein Sept. 19, 2020 Reprints Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. @adamfeuerstein Tags biotechnologycancerESMO20pharmaceuticalsSTAT+last_img read more

S&P cuts outlook for Ontario

James Langton B.C. budget forecasts three years of billion-dollar deficits Ontario to deliver its second pandemic budget on March 24 Standard & Poor’s Ratings Services Wednesday revised its outlook on the province of Ontario to negative from stable on concerns about its deficit reduction plan. S&P said the province’s main credit challenges include its continuing weak budgetary and debt metrics and its challenging cost-containment plan required to achieve budgetary balance by fiscal 2018. “The outlook revision reflects our view regarding the minority legislature’s ability to meet challenging cost-containment targets in the next one-to-two years necessary for the debt burden to peak in fiscal 2015 as planned,” said Standard & Poor’s credit analyst Mario Angastiniotis. Ontario unlikely to balance budget by 2030: FAO Keywords Budgets,  OntarioCompanies Standard & Poor’s At the same time, S&P affirmed its current ratings on the province, citing its large, wealthy, and well-diversified economy, which continues to recover, albeit unevenly, from the recession; ongoing support from the federal government; and positive liquidity. However, S&P notes that, given the deterioration in the global economy in the latter half of 2011, “the government has been forced to rely more heavily on spending measures in this budget to counteract potentially softer revenue growth.” It says the cornerstones of its plan are a two-year public sector salary freeze, pension plan cost containment, some job reductions, and a number of cost avoidance measures. ” In our view, the government will need to be successful in implementing these measures in order for it to hold program spending growth to a 1% average annual rate in fiscal 2012-2015,” it says. But the rating agency believes that it will be a challenge for any province to sustain this low growth rate in spending, “due to the substantial cost pressures in health care delivery alone.” S&P says the negative outlook indicates that there is at least a one-in-three likelihood that it could lower the long-term rating one notch within two years. “Although we believe that the government’s fiscal plan is based on cautious near-term economic assumptions, its success is tied to significant savings measures that could prove challenging to achieve,” it concludes. Facebook LinkedIn Twitter Share this article and your comments with peers on social media Related news read more

One new positive case

first_imgThe Caribbean Public Health Agency today (April 21, 2020) reported six (6) more negative COVID-19 and one (1) new positive result for St. Vincent and the Grenadines. Oct 16, 2020 One of the negative results provided medical clearance and confirms this country’s third recovered COVID-19 case. You may be interested in… The Government of St. Vincent and the Grenadines will continue to keep the public informed as we manage this public health challenge together. Share this:PrintTwitterFacebookLinkedInLike this:Like Loading… COVID -19 Update SVG: One more positive, six negative, one more recoveredSt. Vincent and the Grenadines has recorded its fourteenth (14) positive COVID -19 case. Today’s new case is closely associated with the one which was reported on Tuesday, April 21, by the Caribbean Public Health Agency CARPHA, the first since April 9, 2020. Chief Medical Officer, Dr Simone Keizer Beache,…April 23, 2020In “General”No new positives, 3 negative results – COVID -19, SVGThe Caribbean Public Health Agency on Sunday reported another three (3) negative COVID-19 results for St. Vincent and the Grenadines. One (1) of these negative tests was for an isolated patient who had previously tested positive, and is part of the medical clearance process to determine whether the patient had…April 20, 2020In “General”Additional COVID-19 Results for SVG: Three Negative and One PositiveAPI, SVG, 7 April – The Caribbean Public Health Agency has reported results on an additional 4 samples that were sent for testing – three were negative for COVID-19 and one was positive for COVID-19. These results bring the total number of positive cases of COVID-19 in St. Vincent and…April 7, 2020In “General”Share this on WhatsApp Six Eastern Caribbean countries deemed safe for travel – CDC This new case of COVID-19 serves as a reminder about the importance of maintaining the public health measures currently in place, which include hand hygiene, cough etiquette, physical distancing of at least 3-6 ft in public spaces, and strict adherence to quarantine and isolation. More deaths from COVID-19 recorded in CARICOM countries,… St. Lucia records more cases of COVID CMO says Saint Lucia at critical stage of COVID-19 outbreak These measures are vital, if we are to continue to slow the spread of COVID-19 in St Vincent and the Grenadines. Oct 15, 2020 The new positive COVID-19 case, which remains under investigation, brings the total number of confirmed cases in St. Vincent and the Grenadines to thirteen (13). Oct 15, 2020 There are therefore three (3) recovered COVID-19 cases in St. Vincent and the Grenadines. Oct 16, 2020last_img read more

PBA lifts lifetime ban on Renaldo Balkman

first_imgBalkman, who played for New York Knicks and Denver Nuggets in the NBA, was meted the suspension after choking his Petron Blaze Boosters (now San Miguel Beermen) teammate Arwind Santos in 2013. He was also slapped with a P250,000 fine.“I trust that Balkman has learned his lesson,” Salud wrote the league.Sheryl Reyes, who represented Balkman in the Philippines, said she was thankful that the PBA welcomed the player back.She thanked Salud and Marcial for “giving him (Blakman) a second chance.” “God is good,” she said.The 33-year-old Balkman currently plays for San Miguel Beer-Alab Pilipinas in the 2018 ASEAN Basketball League./PN Renaldo Balkman may again play in the Philippine Basketball Association after the league lifted the lifetime ban on him. SPIN.PH MANILA – Puerto Rican forward Renaldo Balkman may now return as import in the PBA after the league decided to lift its lifetime ban on him.PBA Commissioner Willie Marcial confirmed the lifting of the ban on the former NBA forward after getting a nod from former PBA commissioner Angelico “Chito” Salud, who imposed the penalty.“He (Balkman) wrote a letter of appeal, then personally appeared in my office,” said Marcial. “But I didn’t decide based on just that. I solicited the thoughts of Commissioner Chito Narvasa and Arwind Santos. Both gave their thumbs-up for the lifting of the ban.”“Balkman was apologetic and gave assurance for his behavior on and off the court. He has matured since the incident now that he’s 33,” Marcial added. read more